首页行业分类生物医药生物2023-04-27-天风证券-长春高新-聚焦生物医药加速产品布局,Q2业绩有望迎来拐点
PDF

2023-04-27-天风证券-长春高新-聚焦生物医药加速产品布局,Q2业绩有望迎来拐点

问**馆3页687.16K

下载文档
/3
全屏查看
2023-04-27-天风证券-长春高新-聚焦生物医药加速产品布局,Q2业绩有望迎来拐点
还有 3 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 3 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
公司报告ㄧ季报点评天风证券TF SECURITIES财务预测摘要202120222023E2024E2025E202120222023E2024E2025E货币资金5743.12557851128580511494.7020.9780610,746.7212627.1915,208.1717,4013220,116.432439511516303533072272241514871.906202.193.05967.121096.93704061720.42108774营业税金及附加134.71106362112318507存货4360.09228662723153416910销售费用3806974675.705.199295.99890其他1395831529.772396.94281036632.9682371920311.046061230.9214,040.8115,298.793131751研发费用884501358331123321398091.72754977.18106030126044140455154701财务费用25132)固定资产2223.19322733370952399679资产信用减值损失(12517刀126.65⑤989100.95)在建工程2042572299272.77909393100公允价值变动收益110000(3983)无形资产1822872240312.624442923.59317591投资净收益3478(75.71)2403(4222)(44.19)其他1409.161902.36112072101385其他231.19346930.008474.9610,728.5712583644,715.446,808.717,737648,961.9622515.7726,0273631,119.0238,9603044972.07营业外收入78117.099751141115280.0089.0057.49557912858营业外支出608066527474623.75628.523141495112573314924.156,753.408,898.74其他2389.934464.09329140所得税71923709241.171541351963,092.683,285.613455.725,471003993293897464214.915,703.996510.997548.7871240634.9957491557851285807480537.613692439607应付债券450.00450.003375042188414843,757.474,140.116141747,160.71其他3412232527392553333734810928102312.77151817.691503.621410251304.961313102048755278.955,220.876,784106042.043240053573243922A4202120222023E2024E2025E404.72404.72404714047140471资本公积3404.753.404753404.753404752530%17502044%144215.60%11091211489953195445425.086.5831563541980%535%3706%1582%其他(27369(65919235.70)(365410日属于母公司净利润2333%101%2479%16.59%17238.82283583432,1762038,930.0322515.7726,0273631,119.0244972.07毛利率净利率3496%3279%3397%3529%35.60%ROE2578%2294%2235%2147%20.45%ROIC4431%3584%3787%35.77%202120222023E2024E2025E净利润3897.464214.915.166386141.747.16071资产负债率2345%1530%17.41%13.44%283.9140121528316155771406净负债率-2007%-44.64%3204%财务费用3422370717835)(3245月流动比率372401574482784投资损失75.71240342224419256279680营运资金变动152889322170290327其它609.135578959415329416306933330.622,826.419356.2210,89536292280353资本支出2550.442154.601.591131880.74170102总资产周转率055052050.50长期投资83.13200141441114246其他44929司(3571.17)(360837102312.77151817.692,25523(1,78489)82323.121.90144.034.40134.64)347.0011558436.0144605712(10037(746910152.15)其他763.16000000(000市盈率172315641253105490480681市净率4443592261850.000.000000.000.0018.007.535061,71123(205.01)727954(136334)94933610.00812741547资料来源:公司公告,天风证券研究所请务必阅读正文之后的信息披露和免责申明2